Wolverine + KPV – 10mg / 10mg / 10mg

$200.00

 BPC-157 – 10mg / TB500 – 10mg / KPV – 10mg

The Wolverine + KPV Blend (10mg / 10mg / 10mg) is an elite triple-peptide research formulation engineered to explore maximum regenerative and anti-inflammatory synergy. By combining an angiogenic gastric protection peptide (BPC-157) and an actin-sequestering motility protein (TB-500) with an advanced NF-kB inhibiting neuropeptide (KPV), this formulation serves as a premier investigative tool for tracking rapid tissue repair, gut barrier integrity, and deep cellular inflammation reduction in laboratory models.

Supplied as a stable, high-purity lyophilized powder blend in a single 30mg total mass vial. *MUST BE RECONSTITUTED FOR RESEARCH APPLICATIONS.* Restricted strictly to laboratory and in vitro evaluation.

Description

Eterna Peptides presents the premium, high-purity “Wolverine + KPV Blend” containing BPC-157 (10mg), TB-500 (10mg), and KPV (10mg) lyophilized powder. This advanced triple-peptide formulation unites three of the most heavily researched regenerative and immunomodulatory compounds to study multi-pathway tissue healing, deep cellular repair, and mucosal/systemic inflammation reduction.

Mechanism of Action
The Wolverine + KPV Blend leverages an unparalleled synergistic matrix, utilizing three distinct biological pathways to accelerate structural recovery and shut down inflammatory cascades:
* **BPC-157 (Body Protection Compound-157):** A stable, 15-amino acid synthetic peptide sequence derived from human gastric juice. Research indicates it upregulates growth hormone receptors, promotes rapid cellular migration, and triggers angiogenic (new blood vessel) pathways via VEGF expression to repair low-vascularity tissues.
* **TB-500 (Thymosin Beta-4 Fragment):** A synthetic segment of the naturally occurring 43-amino acid peptide, Thymosin Beta-4. Its primary action focuses on actin-sequestering, a process critical for cell motility, myofibrillar cell alignment, and deep structural remodeling at injury sites.
* **KPV (Lysine-Proline-Valine):** A highly potent C-terminal peptide fragment of alpha-melanocyte-stimulating hormone ($\alpha$-MSH). KPV exerts powerful anti-inflammatory effects by interacting directly with MC1 receptors and entering the cell to inhibit NF-$\kappa$B, the master signaling pathway responsible for inflammatory cytokine production.

Research Applications
In preclinical and in vitro laboratory models, the BPC-157 / TB-500 / KPV blend is extensively investigated to study:
* Accelerated structural repair of tendons, ligaments, skeletal muscles, and dense connective tissues.
* Advanced mitigation of chronic inflammatory conditions, mast cell activation, and autoimmune tissue responses.
* Gastrointestinal mucosal healing, intestinal barrier integrity, and inflammatory bowel research.
* Multi-angle angiogenesis and microvascular perfusion restoration at localized injury sites.

Our Wolverine + KPV Blend vials are precision-manufactured under strict quality control standards to guarantee perfect component ratios, maximum structural purity, and exceptional analytical consistency across all experimental models.


*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*

Menu

Research Categories